Environment is shared by variety of domestic animals as companion, food source, transportation, leisure, research & pets inside and outside home. The variety of species are kept in households primarily dogs and cats which creates profound health effect on humans along with animals and they need to be protected. To protect the animals as well as family from diseases and maintaining their health owners have to vaccinate their pets on the regular basis. It helps in evading disease among various animals and also helps in enhancing production of livestock. For monitoring disease and diagnosis of domestic animals, diagnostic imaging technique is used such as magnetic resonance imaging (MRI) & computed tomography (CT). In U.S, 62% of households own a companion animals and with increasing preference for companion animals is witness the demand for companion animal vaccines in near future.

Companion Animal Vaccines Market: Drivers and Restraints
With increased prevalence of animal disease along with increasing incidence of zoonotic disease, animal welfare and government investment are some of the key factors that drives the market for companion animal vaccines. Increase in the cost of vaccines, ignorance and preference towards vegetarian food is proving a major challenge for companion animal vaccines market.

Companion Animal Vaccines Market: Segmentation
The companion animal vaccines market has been classified on the basis of product, disease and technology.
Based on product type, the companion animal vaccines market is segmented into the following:
• Canine
• Feline

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1427

Based on disease type, the companion animal vaccines market is segmented into the following:
Canine Vaccines
• Canine Rabies
• Canine Distemper
• Canine Parvovirus
• Canine Hepatitis
• Others

Feline Vaccines
• Feline Rabies
• Feline Panleukopenia
• Feline Viral Rhinotracheitis
• Feline Leukemia
• Others

Based on technology type, the companion animal vaccines market is segmented into the following:
• Live Attenuated Vaccines (LAV)
• Subunit Vaccines
• Inactivated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• DNA Vaccines
• Conjugate Vaccines

Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1427

Companion Animal Vaccines Market: Overview
Research and development activities, new product development along with various collaborations and prominent strategies adopted by various vaccine manufactures to enhance and expand their market share are propelling the growth of companion animal vaccines market during the forecast period.

Companion Animal Vaccines Market: Region-wise Outlook
Depending on geographic region, companion animal vaccines market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. Europe accounts for largest market share of the global companion animal vaccines market followed by North America, Japan and Asia Pacific owing to high awareness among population and increase in the preference for owning companion animals. The developing nations in Latin America, Middle East and Africa hold huge potential and a promising market for companion animal vaccines market due to increase in investment opportunities and vast untapped market.

Syndicated Market Research Reports@ http://www.futuremarketinsights.com/reports

Companion Animal Vaccines Market: Key Players
Key players of companion animal vaccines market are Bayer Healthcare, Merial Inc. (Sanofi), Bioniche animal Health (Canada), Boehringer Ingelheim (Germany), Zoetis (U.S), Heska Corporation, Merck Animal Health (U.S), Novartis Animal Health Inc., Virbac and others.